TrialBreast cancer research and treatment2018

Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib + letrozole: results from MONALEESA-2.

Sunil Verma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.